Clinical Trials Logo

Filter by:
NCT ID: NCT05663645 Completed - Infertility Clinical Trials

Navigating Health Insurance Selection for IVF Benefits

Start date: November 9, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effectiveness of an educational intervention on health insurance literacy and utilization of in vitro fertilization (IVF) insurance benefits. The investigators hypothesize that the intervention is acceptable and satisfactory and will result in increased health insurance literacy and utilization of IVF benefits.

NCT ID: NCT05662631 Completed - Clinical trials for Bone Marrow Transplant

Remote Monitoring and Home-based Health Care for Treatment of Bone Marrow Transplant Patients

Start date: March 31, 2022
Phase: N/A
Study type: Interventional

This study is designed to assess the potential for successfully using technology-assisted in-home oncology care, including remote patient monitoring (RPM), telemedicine, and home-based health care services to support improved care management and appropriate referral to treatment for bone marrow transplant (BMT) patients.

NCT ID: NCT05662592 Completed - Pigmentation Clinical Trials

Evaluation of Broadband Light Treatment Protocol for Pigmented Skin Lesions - A Comparative Study

Start date: October 1, 2022
Phase: N/A
Study type: Interventional

Evaluation of Broadband Light Treatment Protocols for Pigmented Skin Lesions - A comparative study

NCT ID: NCT05661851 Completed - Dry Eye Clinical Trials

Clinical Evaluation of a Multidose Preservative-free Lubricating Eye Drops Contained in Novelia® Eye Dropper in Non-Contact Lens Wearing Patients

Start date: February 23, 2023
Phase: Phase 2
Study type: Interventional

This is a 30-Day, multi-site, single-masked, bilateral, active- controlled, 2-Arm parallel group study to evaluate the safety and efficacy of an Investigational product.

NCT ID: NCT05661734 Completed - Pain Clinical Trials

A Single-arm Study to Evaluate Safety and Effectiveness of VX-548 for Acute Pain

Start date: January 9, 2023
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety and effectiveness of VX-548 in treating acute pain.

NCT ID: NCT05661604 Completed - Clinical trials for Acute Respiratory Viral Infection

A Study to Investigate Acute Respiratory Virus Infections in Participants at High Risk for Severe Illness

BREEZE
Start date: January 19, 2023
Phase:
Study type: Observational

The purpose of the study is to describe the rate of occurrence of clinical diagnosis of acute respiratory infection (an infection that affects normal breathing) and different types of respiratory pathogens (harmful organisms) of new respiratory infections in a population at high risk for severe illness.

NCT ID: NCT05660681 Completed - Dry Eye Disease Clinical Trials

Evaluation of the Tolerability and Efficacy of CWT-f-002 Lubricant Eye Drops

Start date: December 12, 2022
Phase: N/A
Study type: Interventional

The primary objective is to evaluate the tolerability and efficacy of CWT-f-002 lubricant eye drops in the treatment of the signs and symptoms of dry eye disease.

NCT ID: NCT05660577 Completed - Clinical trials for Myopia and Hyperopia and Presbyopia

Evaluation of Product Performance of a New Silicone Hydrogel Multifocal Contact Lens

Start date: November 7, 2022
Phase: N/A
Study type: Interventional

The objective of this study is to evaluate the product performance of a new silicone hydrogel daily disposable multifocal contact lens, the Bausch + Lomb (kalifilcon A) Daily Disposable Multifocal Contact Lens, when worn by current soft contact lens wearers on a daily disposable wear basis

NCT ID: NCT05660538 Completed - Clinical trials for Diabetic Peripheral Neuropathy

Evaluation of Efficacy and Safety of VX-548 for Painful Diabetic Peripheral Neuropathy (DPN)

Start date: December 20, 2022
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of VX-548 doses in treating Painful DPN.

NCT ID: NCT05660434 Completed - Clinical trials for Substance Use Disorders

Using Aromatherapy in Substance Use Disorder

Start date: September 5, 2022
Phase: N/A
Study type: Interventional

The purpose of this clinical trial study is to see if Bergamot, an aroma therapy essential oil, has any effect on comfort, ease, and stress. Participants will be asked to use a bergamot aroma inhaler, which is a small tube about the size of a lipstick container, at least three times a day for one week. Comfort, ease, and stress will be measured with self-report survey at the beginning and at the end of the week. In addition, participants will be asked to complete a daily logbook to record use of the inhaler. The study lasts for one week (7 days). The aims of this study are to explore the effects of Bergamot essential oil on comfort, ease, and stress in adults in a SUD treatment program, and to evaluate the feasibility of this type of aroma therapy intervention.